130 related articles for article (PubMed ID: 16102265)
1. Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces.
Nishida K; Kuma A; Fumoto S; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2005 Aug; 57(8):1073-7. PubMed ID: 16102265
[TBL] [Abstract][Full Text] [Related]
2. Absorption characteristics of model compounds with different molecular weights from the serosal caecal surface in rats.
Nishida K; Nose S; Kuma A; Mukai T; Kawakami S; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
J Pharm Pharmacol; 2002 Jul; 54(7):1005-9. PubMed ID: 12162704
[TBL] [Abstract][Full Text] [Related]
3. Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats.
Nishida K; Tomiyama N; Mukai T; Nakashima M; Sasaki H; Nakamura J
Eur J Pharm Biopharm; 2004 Nov; 58(3):705-11. PubMed ID: 15451548
[TBL] [Abstract][Full Text] [Related]
4. Delivery advantage to the unilateral kidney by direct drug application to the kidney surface in rats and pharmacokinetic verification based on a physiological model.
Nishida K; Kamenosono M; Kuma A; Fumoto S; Mukai T; Nakashima M; Sasaki H; Nakamura J
J Drug Target; 2005 May; 13(4):215-23. PubMed ID: 16051533
[TBL] [Abstract][Full Text] [Related]
5. Absorption characteristics of dextrans with different molecular weights from the liver surface membrane in rats: implications for targeting to the liver.
Nishida K; Sato N; Sasaki H; Nakamura J
J Drug Target; 1996; 4(3):141-50. PubMed ID: 8959486
[TBL] [Abstract][Full Text] [Related]
6. Does bacitracin have an absorption-enhancing effect in the intestine?
Gotoh S; Nakamura R; Nishiyama M; Fujita T; Yamamoto A; Muranishi S
Biol Pharm Bull; 1995 May; 18(5):794-6. PubMed ID: 7493005
[TBL] [Abstract][Full Text] [Related]
7. Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
Onishi H; Imura Y; Uchida M; Machida Y
Curr Drug Deliv; 2012 Sep; 9(5):487-94. PubMed ID: 22520068
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of changes in hepatic disposition of phenolsulfonphthalein, indocyanine green and fluorescein isothiocyanate-dextran at low temperatures using a rat liver perfusion system.
Miyamoto H; Miyake H; Yoshikawa N; Hirata H; Ohwaki Y; Fumoto S; Sasaki H; Nakamura J; Nishida K
J Pharm Pharmacol; 2012 Jun; 64(6):848-54. PubMed ID: 22571263
[TBL] [Abstract][Full Text] [Related]
9. Absorption of phenolsulfonphthalein as a model across the mesenteric surface in rats to determine the drug absorption route after intraperitoneal administration.
Nishida K; Nose S; Kuma A; Mukai T; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2004 May; 56(5):683-7. PubMed ID: 15142348
[TBL] [Abstract][Full Text] [Related]
10. Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.
Gotoh S; Nakamura R; Nishiyama M; Quan YS; Fujita T; Yamamoto A; Muranishi S
J Pharm Sci; 1996 Aug; 85(8):858-62. PubMed ID: 8863277
[TBL] [Abstract][Full Text] [Related]
11. Regional delivery of model compounds and 5-Fluorouracil to the liver by their application to the liver surface in rats: its implication for clinical use.
Nishida K; Fujiwara R; Kodama Y; Fumoto S; Mukai T; Nakashima M; Sasaki H; Nakamura J
Pharm Res; 2005 Aug; 22(8):1331-7. PubMed ID: 16078143
[TBL] [Abstract][Full Text] [Related]
12. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
13. Influence of various combinations of mucolytic agent and non-ionic surfactant on intestinal absorption of poorly absorbed hydrophilic compounds.
Takatsuka S; Morita T; Horikiri Y; Yamahara H; Saji H
Int J Pharm; 2008 Feb; 349(1-2):94-100. PubMed ID: 17869034
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats.
Maeda T; Miyazono Y; Ito K; Hamada K; Sekine S; Horie T
Cancer Chemother Pharmacol; 2010 May; 65(6):1117-23. PubMed ID: 19756603
[TBL] [Abstract][Full Text] [Related]
15. Change in pharmacokinetics of model compounds with different elimination processes in rats during hypothermia.
Nishida K; Okazaki M; Sakamoto R; Inaoka N; Miyake H; Fumoto S; Nakamura J; Nakashima M; Sasaki H; Kakumoto M; Sakaeda T
Biol Pharm Bull; 2007 Sep; 30(9):1763-7. PubMed ID: 17827736
[TBL] [Abstract][Full Text] [Related]
16. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin.
Ito Y; Ise A; Sugioka N; Takada K
Drug Dev Ind Pharm; 2010 Jul; 36(7):845-51. PubMed ID: 20180657
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
18. Alleviation by garlic of antitumor drug-induced damage to the intestine.
Horie T; Awazu S; Itakura Y; Fuwa T
J Nutr; 2001 Mar; 131(3s):1071S-4S. PubMed ID: 11238819
[TBL] [Abstract][Full Text] [Related]
19. Effect of instillation method on the absorption of phenolsulphonphthalein as a model drug from the liver and small intestinal serosal surface in rats.
Nishida K; Yoshida Y; Mukai T; Kawakami S; Sakaeda T; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2001 Oct; 53(10):1341-6. PubMed ID: 11697541
[TBL] [Abstract][Full Text] [Related]
20. The structural barrier of absorptive mucosae: site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits.
Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y; Yamashita S
Biopharm Drug Dispos; 1993 Nov; 14(8):685-95. PubMed ID: 7508274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
